{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:37:49Z","timestamp":1791322669614,"version":"4.3.1"},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":152,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Muscle Nerve"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1002\/mus.24653","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T18:56:59Z","timestamp":1426705019000},"page":"884-889","source":"Crossref","is-referenced-by-count":27,"title":["SHOULD patients with asymptomatic pompe disease be treated? A nationwide study in france"],"prefix":"10.1002","volume":"51","author":[{"given":"Andoni","family":"Echaniz-Laguna","sequence":"first","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence des Maladies Neuromusculaires, D\u00e9partement de Neurologie; H\u00f4pital de Hautepierre 1; Avenue Moli\u00e8re 67098 Strasbourg France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert-Yves","family":"Carlier","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris (APHP), Service d'imagerie m\u00e9dicale, CIC-IT handicap; H\u00f4pital Poincar\u00e9; Garches France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenza","family":"Laloui","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence Neuromusculaire Paris-Est, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, and U974; Universit\u00e9 Pierre et Marie Curie; Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Carlier","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence Neuromusculaire Paris-Est, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, and U974; Universit\u00e9 Pierre et Marie Curie; Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Salort-Campana","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence des Maladies Neuromusculaires; Aix-Marseille Universit\u00e9, APHP; Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Pouget","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence des Maladies Neuromusculaires; Aix-Marseille Universit\u00e9, APHP; Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Laforet","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence Neuromusculaire Paris-Est, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, and U974; Universit\u00e9 Pierre et Marie Curie; Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,4,2]]},"reference":[{"key":"10.1002\/mus.24653-BIB0001|mus24653-cit-0001","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"Ploeg","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/mus.24653-BIB0002|mus24653-cit-0002","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid alfa-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1002\/mus.24653-BIB0003|mus24653-cit-0003","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"Ploeg","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1002\/mus.24653-BIB0004|mus24653-cit-0004","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2012.09.015","article-title":"Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa","volume":"107","author":"Ploeg","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1002\/mus.24653-BIB0005|mus24653-cit-0005","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1212\/WNL.0b013e318228c0ea","article-title":"Making diagnosis of Pompe disease at a presymptomatic stage: to treat or not to treat?","volume":"77","author":"Laloui","year":"2011","journal-title":"Neurology"},{"key":"10.1002\/mus.24653-BIB0006|mus24653-cit-0006","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nmd.2012.09.004","article-title":"Presymptomatic late-onset Pompe disease identified by the dried blood spot test","volume":"23","author":"Wagner","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1002\/mus.24653-BIB0007|mus24653-cit-0007","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2013.03.002","article-title":"Screening for later-onset Pompe's disease in patients with paucisymptomatic hyperCKemia","volume":"109","author":"Spada","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1002\/mus.24653-BIB0008|mus24653-cit-0008","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1212\/WNL.0b013e318228c15f","article-title":"\u201cI'm fine; I'm just waiting for my disease\u201d: the new and growing class of presymptomatic patients","volume":"77","author":"Kwon","year":"2011","journal-title":"Neurology"},{"key":"10.1002\/mus.24653-BIB0009|mus24653-cit-0009","first-page":"595","article-title":"The French Pompe registry","volume":"169","author":"Lafor\u00eat","year":"2013","journal-title":"Baseline characteristics of a cohort of 126 patients with adult Pompe disease. Rev Neurol"},{"key":"10.1002\/mus.24653-BIB0010|mus24653-cit-0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mus.21393","article-title":"Diagnostic criteria for late-onset (childhood and adult) Pompe disease","volume":"40","author":"American Association of Neuromuscular & Electrodiagnostic Medicine","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1002\/mus.24653-BIB0011|mus24653-cit-0011","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.nmd.2011.06.748","article-title":"Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: involvement patterns","volume":"21","author":"Carlier","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1002\/mus.24653-BIB0012|mus24653-cit-0012","unstructured":"www.pompecenter.nl 2014"},{"key":"10.1002\/mus.24653-BIB0013|mus24653-cit-0013","unstructured":"http:\/\/genetics.bwh.harvard.edu\/pph2\/ 2013"},{"key":"10.1002\/mus.24653-BIB0014|mus24653-cit-0014","unstructured":"http:\/\/sift.jcvi.org\/ 2013"},{"key":"10.1002\/mus.24653-BIB0015|mus24653-cit-0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ymgme.2011.06.012","article-title":"Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease","volume":"104","author":"Beek","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1002\/mus.24653-BIB0016|mus24653-cit-0016","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1750-1172-8-182","article-title":"Phenotypical variation within 22 families with Pompe disease","volume":"8","author":"Wens","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1002\/mus.24653-BIB0017|mus24653-cit-0017","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jnnp-2011-301593","article-title":"Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry","volume":"83","author":"Lucia","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/mus.24653-BIB0018|mus24653-cit-0018","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajmg.c.31318","article-title":"The genotype-phenotype correlation in Pompe disease","volume":"160C","author":"Kroos","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1002\/mus.24653-BIB0019|mus24653-cit-0019","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2012.05.016","article-title":"Can genes influencing muscle function affect the therapeutic response to enzyme replacement therapy (ERT) in late-onset type II glycogenosis?","volume":"107","author":"Ravaglia","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1002\/mus.24653-BIB0020|mus24653-cit-0020","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","article-title":"Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review","volume":"260","author":"Toscano","year":"2013","journal-title":"J Neurol"}],"container-title":["Muscle &amp; Nerve"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmus.24653","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/mus.24653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T04:32:28Z","timestamp":1625459548000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mus.24653"}},"subtitle":["Asymptomatic Pompe Disease"],"short-title":[],"issued":{"date-parts":[[2015,4,2]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.1002\/mus.24653","relation":{},"ISSN":["0148-639X"],"issn-type":[{"value":"0148-639X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4,2]]}}}